FDA Clearance Tracker · P150038-S010
Exablate 4000 (Neuro) Type 1.0 & 1.1
Last checked: Nov 20, 2026Latest source record: Nov 9, 2020 (this decision)Source: openFDAMethods & limitations
Decided
Nov 9, 2020
Approved
Time to decision
647 days
Received Feb 1, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
Device type
- Device type
- MR-guided focused ultrasound system (POH)
- Device class
- Class III
- Specialty
- Neurology & Neurosurgery
FDA's approval statement
As written in FDA's record.
Approval of the revised protocol, Protocol Number PD012 Version 1, amended on April 28, 2020, for the post-approval study (PAS) protocol.
Source documents
Other decisions for Insightec
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Exablate Model 4000 Type-1 SystemPMA supplement
P150038-S037 · Decided Jul 3, 2025 · 352 days after receipt · Panel Track
Device type: MR-guided focused ultrasound system (POH) · Neurology & Neurosurgery
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.